REQUEST A DEMO
Total
USD $0.00
Search more companies

Apteka Neboleika Plus OOO (Аптека Неболейка Плюс ООО) (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: Apteka Neboleika Plus OOO Profile Updated: March 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Apteka Neboleika Plus OOO (Аптека Неболейка Плюс ООО) is based in Russia. The head office is in Saint Petersburg. It operates in the Pharmacies and Drug Stores industry. The company was established on August 02, 2017. From the latest financial highlights, Apteka Neboleika Plus OOO (Аптека Неболейка Плюс ООО) reported a net sales revenue increase of 42.36% in 2024. Its’ total assets recorded a growth of 0.41%. In, 2024, the company’s net profit margin decreased by 0.31%.

Headquarters
Lunacharskogo, 72, 1 Liter A, 34N
Saint Petersburg; Saint Petersburg; Postal Code: 194291

Contact Details: Purchase the Apteka Neboleika Plus OOO (Аптека Неболейка Плюс ООО) report to view the information.

Basic Information
Financial Auditors:
Purchase the Apteka Neboleika Plus OOO (Аптека Неболейка Плюс ООО) report to view the information.
Incorporation Date:
August 02, 2017
Company Performance
Financial values in the chart are available after Apteka Neboleika Plus OOO (Аптека Неболейка Плюс ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
42.36%
Total operating revenue
42.36%
Operating profit (EBIT)
37.87%
Net Profit (Loss) for the Period
35.29%
Total Assets
0.41%
Total Equity
27.26%
Operating Profit Margin (ROS)
-0.26%
Net Profit Margin
-0.31%
Return on Equity (ROE)
4.25%
Quick Ratio
-0.23%
Cash Ratio
-0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?